C5aR antibodies (Shanghai PharmaExplorer)

N/A

Report date: 2025/03/14 16:34:16

Base Information

Drug NameC5aR antibodies (Shanghai PharmaExplorer)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > AntibodyBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionC5a anaphylatoxin chemotactic receptor modulators
TargetsC5a anaphylatoxin chemotactic receptor
Therapy Area/IndicationsInflammationVascular DiseasesNervous System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesShanghai Blazers Biomedical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShanghai Blazers Biomedical Co Ltd
Inactive CompaniesN/A
Active IndicationsInflammationVascular DiseasesNervous System Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A